Detalhe da pesquisa
1.
GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies.
J Immunother Cancer
; 10(12)2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36460335